75. DMT for Depression with Dr Graham Campbell

The Drug Science Podcast - A podcast by Drug Science - Wednesdays

Categories:

Are you curious about the potential therapeutic benefits of psychedelic-assisted therapy? Tune in to this week's episode of our podcast, where we have a fascinating conversation with Dr. Graham Campbell, a renowned consultant psychiatrist and researcher in the field.Drawing from his extensive experience in both psychedelic research and clinical work, Dr. Campbell shares his insights on a range of topics. Discover his thoughts on the possibility of introducing psychedelic treatments by the NHS, the differences between magic mushrooms and DMT in the treatment of depression, and the crucial role of music in a psychedelic journey.Join us for an engaging and informative discussion on the cutting-edge of psychedelic-assisted therapy, with one of the leading experts in the field. Don't miss out - listen to our latest episode now!Listen to Graham's music here! Psychedelic Assisted Therapy Small Pharma DMT Ketamine Intranasal Esketamine (SpravatoTM) for Use in Treatment-Resistant Depression In Conjunction With an Oral Antidepressant Schizophrenia Bipolar disorder Schizoaffective disorder Trial of Psilocybin versus Escitalopram for Depression Rosalind Watts Michelle Baker Jones Roberta Murphy  Jonny Martell Ashleigh Murphy-Beiner Psilocybin Institute of Psychedelic Therapy The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy Sussex Partnership NHS Foundation Trust Ayahuasca Monoamine oxidase inhibitor Serotonin  The ACE Model The hidden therapist: evidence for a central role of music in psychedelic therapy Max Cooper Music and the Mind by Anthony Storr Mind Foundation Maria Papaspyrou ★ Support this podcast ★